Moderna’s stock jumps after biotech raises sales outlook

The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

2 sources · 4 articles · updated 2026-11-06 12:48 UTC · business

Coverage

1. Moderna's stock jumps after biotech raises sales outlook

   Morningstar · 2026-11-06 12:48 UTC

   The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

   Summary on nerom.app

2. Moderna's stock jumps after biotech raises sales outlook

   Morningstar · 2026-11-06 12:16 UTC

   The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

   Summary on nerom.app

3. Moderna’s stock jumps after biotech raises sales outlook

   MarketWatch · 2026-11-06 12:15 UTC

   The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

   Summary on nerom.app

4. Moderna’s stock jumps after biotech raises sales outlook

   MarketWatch · 2026-11-06 12:15 UTC

   The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026

   Summary on nerom.app